Sign up to save your podcasts
Or
Share Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival
Pediatric Pulmonary hypertension (PAH) is a heterogeneous disease, characterized by sustained elevation of pulmonary arterial pressures and death from right ventricular failure. Given the extremely high burden of morbidity and mortality associated with this disease, and the risk of the invasive procedures required for diagnostics, novel biomarkers for this disease would be beneficial. In this episode, we meet Early Career Investigator, Dr. Megan Griffiths from Johns Hopkins University, School of Medicine, who examined two candidate IGF axis proteins as potential predictors of PAH severity.
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By Nature Publishing Group
4.3
44 ratings
Pediatric Pulmonary hypertension (PAH) is a heterogeneous disease, characterized by sustained elevation of pulmonary arterial pressures and death from right ventricular failure. Given the extremely high burden of morbidity and mortality associated with this disease, and the risk of the invasive procedures required for diagnostics, novel biomarkers for this disease would be beneficial. In this episode, we meet Early Career Investigator, Dr. Megan Griffiths from Johns Hopkins University, School of Medicine, who examined two candidate IGF axis proteins as potential predictors of PAH severity.
Hosted on Acast. See acast.com/privacy for more information.
More shows like Pediatric Research Podcast
View all
Nature Podcast
764 Listeners
Eye Podcast
0 Listeners
NPP BrainPod
15 Listeners
Up First from NPR
56,140 Listeners
Charting Pediatrics
261 Listeners
Pediatrics On Call
235 Listeners